Response to letter regarding article, “histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid”

Circulation. 2013 Apr 9;127(14):e540. doi: 10.1161/circulationaha.112.154757.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Histone Deacetylases / drug effects*
  • Humans
  • Hydroxamic Acids / pharmacology*
  • Hydroxamic Acids / therapeutic use*
  • Hypertension, Pulmonary / drug therapy*
  • Male
  • Valproic Acid / pharmacology*
  • Valproic Acid / therapeutic use*

Substances

  • Hydroxamic Acids
  • Valproic Acid
  • Histone Deacetylases